Literature DB >> 11228414

Selection events operating at various stages in B cell development.

A G Rolink1, C Schaniel, J Andersson, F Melchers.   

Abstract

B cells have to progress through various checkpoints during their process of development. The three transcription factors E2A, EBF (early B cell factor) and Pax5 play essential roles in B cell commitment checkpoints. The various forms of the BCR and their downstream signaling molecules, which are expressed at different stages of B cell development, act as critical checkpoint guards allowing (positive selection) or preventing (negative selection) developmental progression. The recent advances on the molecular mechanisms operating at these various checkpoints are here summarized and discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228414     DOI: 10.1016/s0952-7915(00)00205-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  23 in total

1.  Patterns of gene divergence and VL promoter activity in immunoglobulin light chain clusters of the channel catfish.

Authors:  Julia Cay Jones; Seyed H Ghaffari; Craig J Lobb
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

2.  Identification of two new alleles, IGHV3-23*04 and IGHJ6*04, and the complete sequence of the IGHV3-h pseudogene in the human immunoglobulin locus and their prevalences in Danish Caucasians.

Authors:  Line Ohm-Laursen; Stine Rosenkilde Larsen; Torben Barington
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

3.  Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice.

Authors:  Mark D Trottier; Afia Naaz; Yihang Li; Pamela J Fraker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

4.  Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate.

Authors:  Omai B Garner; Yu Yamaguchi; Jeffrey D Esko; Vibeke Videm
Journal:  Immunology       Date:  2008-05-09       Impact factor: 7.397

Review 5.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

6.  Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.

Authors:  Reena Khanna; Barrett G Levesque; William J Sandborn; Brian G Feagan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-08

7.  Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBD.

Authors:  Reena Khanna; Brian G Feagan
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03

8.  Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.

Authors:  Osamu Takeuchi; Jill Fisher; Heikyung Suh; Hisashi Harada; Barbara A Malynn; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

9.  Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.

Authors:  Cigdem Atayar; Sibrand Poppema; Tjasso Blokzijl; Geert Harms; Marcel Boot; Anke van den Berg
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

10.  Contribution of alphabeta and gammadelta T cells to the generation of primary immunoglobulin G-driven autoimmune response in immunoglobulin- mu-deficient/lpr mice.

Authors:  Jane Seagal; Doron Melamed
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.